Emma Long is a chemical biologist with a background in post-translational modifications and their roles in cancer biology.
Prior to joining Jones Day in 2026, Emma received a Ph.D. from the University of Southern California, where she studied O-linked glycosylation (the attachment of carbohydrates to proteins), utilizing carbohydrate chemistry to synthesize metabolic analogues used to visualize, identify, and manipulate glycosylation in vitro. She also completed a post-doctoral fellowship at Bristol Myers Squibb, where she used heterobifunctional molecules to study oncogenic proteins through modulation of phosphorylation and ubiquitination. She has coauthored several peer-reviewed publications, including a book chapter on glycosylation.
- University of Southern California (Ph.D. in Chemistry 2021); Rhodes College (B.S. in Chemistry cum laude 2016)
- Registered to practice before the United States Patent and Trademark Office
Avant d’envoyer cet e-mail, veuillez prendre note de ce qui suit :
Les informations contenues sur le site www.jonesday.com sont destinées à un usage général et ne constituent pas des conseils juridiques. L’envoi et la réception de cet e-mail n’ont pas pour effet de créer une relation avocat-client. Aucun envoi de votre part à un membre du Cabinet ne sera traité comme confidentiel ou protégé à moins que nous n’ayons donné notre accord pour vous représenter. En envoyant cet e-mail, vous confirmez avoir lu et compris la présente notification.